Overproduction of TNF-α by CD8+ type 1 cells and down-regulation of IFN-γ production by CD4+ Th1 cells contribute to toxic shock-like syndrome in an animal model of fatal monocytotropic ehrlichiosis

被引:89
作者
Ismail, N
Soong, L
McBride, JW
Valbuena, G
Olano, JP
Feng, HM
Walker, DH
机构
[1] Univ Texas, Med Branch, Dept Pathol, Ctr Biodefense & Emerging Infect Dis, Galveston, TX 77555 USA
[2] Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA
[3] Univ Texas, Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA
关键词
D O I
10.4049/jimmunol.172.3.1786
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human monocytotropic ehrlichiosis (HME) is an emerging, life-threatening, infectious disease caused by Ehrlichia chaffeensis, an obligate intracellular bacterium that lacks cell wall LPS. We have previously developed an animal model of severe HME using a strain of Ehrlichia isolated from Ixodes ovatus ticks (IOE). To understand the basis of susceptibility to severe monocytotropic ehrlichiosis, we compared low and high doses of the highly virulent IOE strain and the less virulent Ehrlichia muris strain that are closely related to E. chaffeensis in C5713L/6 mice. Lethal infections caused by high or low doses of IOE were accompanied by extensive liver damage, extremely elevated levels of TNF-alpha in the serum, high frequency of Ehrlichia-specific, TNF-alpha-producing CD8(+) T cells in the spleen, decreased Ehrlicha-specific CD4(+) T cell proliferation, low IL-12 levels in the spleen, and a 40-fold decrease in the number of IFN-gamma-producing CD4(+) Th1 cells. All groups contained negligible numbers of IL-4-producing cells in the spleen. Transfer of Ehrlichia-specific polyclonal Abs and IFN-gamma-producing Ehrlichia-specific CD4(+) and CD8(+) type 1 cells protected naive mice against lethal IOE challenge. Interestingly, infection with high dose E. muris provided protection against rechallenge with a lethal dose of IOE. Cross-protection was associated with substantial expansion of IFN-gamma-producing CD4(+) and CD8(+) cells, but not TNF-alpha-producing CD8(+) T cells, a high titer of IgG2a, and a low serum level of TNF-alpha. In conclusion, uncontrolled TNF-alpha production by CD8(+) T cells together with a weak CD4(+) Th1 cell response are associated with immunopathology and failure to clear IOE in the fatal model of HME.
引用
收藏
页码:1786 / 1800
页数:15
相关论文
共 54 条
[21]   Two-step negative enrichment of CD4+ and CD8+ T cells from murine spleen via nylon wool adherence and an optimized antibody cocktail [J].
Gunzer, M ;
Weishaupt, C ;
Planelles, L ;
Grabbe, S .
JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 258 (1-2) :55-63
[22]  
Hack CE, 1997, ADV IMMUNOL, V66, P101, DOI 10.1016/S0065-2776(08)60597-0
[23]   Listeria monocytogenes infection overcomes the requirement for CD40 ligand in exogenous antigen presentation to CD8+ T cells [J].
Hamilton, SE ;
Tvinnereim, AR ;
Harty, JT .
JOURNAL OF IMMUNOLOGY, 2001, 167 (10) :5603-5609
[24]   Bacterial modulins: A novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis [J].
Henderson, B ;
Poole, S ;
Wilson, M .
MICROBIOLOGICAL REVIEWS, 1996, 60 (02) :316-+
[25]   Inhibition of interferon γ induced interleukin 12 production:: A potential mechanism for the anti-inflammatory activities of tumor necrosis factor [J].
Hodge-Dufour, J ;
Marino, MW ;
Horton, MR ;
Jungbluth, A ;
Burdick, RD ;
Strieter, RM ;
Noble, PW ;
Hunter, CA ;
Puré, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) :13806-13811
[26]   MEASUREMENT OF ANTIGEN SPECIFIC LYMPHOCYTE-PROLIFERATION USING 5-BROMO-DEOXYURIDINE INCORPORATION [J].
HUONG, PLT ;
KOLK, AHJ ;
EGGELTE, TA ;
VERSTIJNEN, CPHJ ;
GILIS, H ;
HENDRIKS, JT .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 140 (02) :243-248
[27]   Current status of immune mechanisms of killing of intracellular microorganims [J].
Ismail, N ;
Olano, JP ;
Feng, HM ;
Walker, DH .
FEMS MICROBIOLOGY LETTERS, 2002, 207 (02) :111-120
[28]   Comparison of Ehrlichia muris strains isolated from wild mice and ticks and serologic survey of humans and animals with E-muris as antigen [J].
Kawahara, M ;
Ito, T ;
Suto, C ;
Shibata, S ;
Rikihisa, Y ;
Hata, K ;
Hirai, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (04) :1123-1129
[29]  
LEIST M, 1994, J IMMUNOL, V153, P1778
[30]  
LEIST M, 1995, AM J PATHOL, V146, P1220